Aandelen in “Productie van biologische producten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Cardiff Oncology Inc |
30/04 | 2,740 USD
-1,44% |
-1,44% |
|
CASI Pharmaceuticals Inc |
30/04 | 1,940 USD
-2,76% |
-2,76% |
|
Cel-Sci Corp. |
30/04 | 0,290 USD
0,00% |
0,00% |
|
Celldex Therapeutics Inc. |
30/04 | 20,830 USD
-0,48% |
-0,48% |
|
Cellectis |
30/04 | 1,645 USD
+3,46% |
+3,46% |
Cellectis |
30/04 | 1,396 EUR
+0,43% |
+0,43% |
|
Champions Oncology Inc |
30/04 | 7,150 USD
-4,92% |
-4,92% |
|
Cidara Therapeutics Inc |
30/04 | 20,885 USD
-1,11% |
-1,11% |
|
Coherus Biosciences Inc |
30/04 | 1,030 USD
+3,04% |
+3,04% |
|
CRISPR Therapeutics AG |
30/04 | 38,670 USD
+3,40% |
+3,40% |
|
Curis Inc |
30/04 | 2,110 USD
+16,57% |
+16,57% |